Supporting a pathogenic contribution for XBP1 mRNA in ALS is the finding that SOD1-ALS mice lacking the XBP-1 gene display reduced mutant SOD1 aggregates and are more resistant to developing ALS-related pathological decline [125]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.